Archive - February 2025
Are Hormonal Birth Control Methods Safe? Contraceptives That May Increase Risk Of Heart Attack And Stroke
Andembry treatment approved across Europe
Illuccix therapy gets approval in the UK
PanK4 identified as a regulator of glucose and lipid metabolism
Salesforce or Veeva: How drugmakers can navigate the upcoming CRM split
Why antibiotics can fail even against non-resistant bacteria
U.S. FDA Approves Expanded Label for Astellas’ Izervay (avacincaptad pegol intravitreal solution) for Geographic Atrophy
U.S. FDA Approves Pfizer’s Adcetris Combination Regimen for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma